Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Sep 7:12:730769.
doi: 10.3389/fpsyt.2021.730769. eCollection 2021.

Worth the Weight? Olanzapine Prescribing in Schizophrenia. A Review of Weight Gain and Other Cardiometabolic Side Effects of Olanzapine

Ita Fitzgerald  1   2 , Sarah O'Dwyer  3 , Margaret Brooks  1 , Laura Sahm  2   4 , Erin Crowley  2 , Ciara Ní Dhubhlaing  1   5
Affiliations

Worth the Weight? Olanzapine Prescribing in Schizophrenia. A Review of Weight Gain and Other Cardiometabolic Side Effects of Olanzapine

Ita Fitzgerald et al. Front Psychiatry. .
No abstract available

Keywords: antipsychotic-induced weight gain; metabolic side effect; metformin; olanzapine; schizophrenia.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

References

    1. Leucht S, Leucht C, Huhn M, Rothe P, Dold M, Bornschein S, et al. . Reducing antipsychotic drugs in stable patients with chronic schizophrenia or schizoaffective disorder: a randomized controlled pilot trial. Eur Arch Psychiatry Clin Neurosci. (2020). Available online at: https://europepmc.org/article/med/32062728 (accessed December 23, 2020). - PMC - PubMed
    1. Leucht S, Tardy M, Komossa K, Heres S, Kissling W, Salanti G, et al. . Meta-analysis on relapse prevention with antipsychotic drugs compared to placebo in schizophrenia. Lancet. (2012) 379:2063–71. 10.1016/S0140-6736(12)60239-6 - DOI - PubMed
    1. Tiihonen J, Tanskanen A, Taipale H. 20-Year nationwide follow-up study on discontinuation of antipsychotic treatment in first-episode schizophrenia. Am J Psychiatry. (2018) 175:765–73. 10.1176/appi.ajp.2018.17091001 - DOI - PubMed
    1. Hjorthøj C, Stürup A, McGrath J, Nordentoft M. Years of potential life lost and life expectancy in schizophrenia: a systematic review and meta-analysis. Lancet Psychiat. (2017) 4:295–301. 10.1016/S2215-0366(17)30078-0 - DOI - PubMed
    1. Galletly C. Premature death in schizophrenia: bridging the gap. Lancet Psychiat. (2017) 4:263–5. 10.1016/S2215-0366(17)30079-2 - DOI - PubMed

LinkOut - more resources